SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bill Rogers who wrote (223)6/4/1997 2:32:00 AM
From: luis a. garcia   of 1115
 
Bill I am still in at 1.50 or so adjusted for a quick trade when it surged forward.. I did not like the action today. The stock was above the 50 and 150 day averages, but the 50 day was not quite over the 150 day..(best I recall) so when the market today fell 19 points a lot of stocks like this one resting on support were toppled and fell below the averages were they picked up downward mommentum due to stop losses normally set under the averages.. so it was a technical event which really does not alter the trade. I spoke with Bud and he recently checked up on it. He is mailing his report tomorrow and was at the publisher.. but he knows of nothing negative.. we are six weeks
away from real news.. plenty of room for the stock to wiggle all over the place. I am tired and perhaps that comes through a bit.. in this market stocks with no earnings get no respect that is part of the trade. Our oportunity to buy low.. and we need to be patient and wait for the results to come out. The preliminary results with phase II kaposi sarcoma were very encouraging and we have something.. here.
If we are not bored out of our skulls first waiting for a little rally to occur.. Unless hard negative news develops I think I will wait on this one to develop. Bud says the FDA is backloged with PMA's and have not been very good about processing some of them quickly..he says a lot buying generally occurs on positive news of phase III completion. Its is the way the industry is.. Any way I will see this one through.. should be heating up at Bud's press time next month.. investment is risky business that is why investors are rewarded so well when they get it right.

bottom line there is no reason for pesimism and there is reason for optimism (phase II kaposi Sarcoma report), The European validations against Zovirax which showed Lidakol is as good as the leading European solution.. I don't remember but I thought it was superior..to its European rival

luis
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext